UCB NORDIC A/S: Financial statements 2018
CVR: 26688949
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
UCB NORDIC A/S (CVR 26688949) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 34,615,000 and a net result of DKK 3,268,000 compared with DKK 3,739,000 the year before. That is a decrease of 0.6% compared with the year before. Equity in the 2018 report amounted to DKK 10,282,000. The solvency ratio was 14.9%. The company had 24 employees in the financial year.
- Gross Profit
- DKK 34,615,000
- Profit/Loss
- DKK 3,268,000
- Equity
- DKK 10,282,000
- Total Assets
- DKK 68,871,000
- Employees
- 24
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 34.6M | 3.3M | 10.3M | 24 |
| 2017 | - | 34.8M | 3.7M | 10.6M | 23 |
| 2016 | - | -35.5M | 3.7M | 10.4M | 25 |
| 2015 | - | 33.7M | 2.1M | 8.2M | - |
| 2014 | - | 33.5M | 2.7M | 8.8M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
UCB NORDIC A/S has published its annual report for 2017. Gross profit came to DKK 34,824,000, and the net result was DKK 3,739,000.
As of May 31, 2018, Per Ove Jonas Berg has joined the board of directors of UCB NORDIC A/S.
As of May 31, 2018, Arnaud Lefèvre has left the board of directors of UCB NORDIC A/S.
As of January 15, 2018, Francois Joseph Gérald Vanier has joined the board of directors of UCB NORDIC A/S.
As of January 15, 2018, Yogesh Naranbhai Khatri has left the board of directors of UCB NORDIC A/S.
About UCB NORDIC A/S
UCB NORDIC A/S is a Danish company of the type Aktieselskab based in København S, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named UCB NORDICS ApS and CELLTECH NORDIC ApS. The management consists of Mari-Ann Retz. The board consists of Laura Ann Byram (chair), Christina Dyreborg Jeppesen and Jaana Mattila. The company is owned by UCB Pharma SA. The company has 48 employees (2026). In 2025, the company reported a gross profit of DKK 88,278,000 and a net result of DKK 6,014,000 compared with DKK 5,226,000 the year before. Equity in the 2025 report amounted to DKK 18,047,000.